119 related articles for article (PubMed ID: 38575193)
81. A multiparametric [
Leithner D; Horvat JV; Bernard-Davila B; Helbich TH; Ochoa-Albiztegui RE; Martinez DF; Zhang M; Thakur SB; Wengert GJ; Staudenherz A; Jochelson MS; Morris EA; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1878-1888. PubMed ID: 31197455
[TBL] [Abstract][Full Text] [Related]
82. Melanin-targeted [
Zhang X; Kang F; Zheng H; Gai Y; Wang J; Lan X
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):196-201. PubMed ID: 37714979
[TBL] [Abstract][Full Text] [Related]
83. Frontoparietal
Balfroid T; Warren AEL; Dalic LJ; Aeby A; Berlangieri SU; Archer JS
Epilepsy Res; 2023 May; 192():107131. PubMed ID: 37054522
[TBL] [Abstract][Full Text] [Related]
84.
Lyra V; Parissis J; Kallergi M; Rizos E; Filippatos G; Kremastinos D; Chatziioannou S
Eur J Heart Fail; 2020 Nov; 22(11):2138-2146. PubMed ID: 32530569
[TBL] [Abstract][Full Text] [Related]
85. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
86. Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis.
Fuster D; Tomás X; Mayoral M; Soriano A; Manchón F; Cardenal C; Monegal A; Granados U; Garcia S; Pons F
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):264-71. PubMed ID: 25186431
[TBL] [Abstract][Full Text] [Related]
87. Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
Maccioni F; Alfieri G; Assanto GM; Mattone M; Gentiloni Silveri G; Viola F; De Maio A; Frantellizzi V; Di Rocco A; De Vincentis G; Pulsoni A; Martelli M; Catalano C
Radiol Med; 2023 May; 128(5):556-564. PubMed ID: 37145214
[TBL] [Abstract][Full Text] [Related]
88. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
Inui Y; Ito K; Kato T;
J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
[TBL] [Abstract][Full Text] [Related]
89. Semiquantitative analysis of cerebral [
Cruz-Cortes Á; Avendaño-Estrada A; Alcauter S; Núñez-Enríquez JC; Rivera-Bravo B; Olarte-Casas MÁ; Ávila-Rodríguez MÁ
Pediatr Radiol; 2023 Dec; 53(13):2574-2585. PubMed ID: 37910188
[TBL] [Abstract][Full Text] [Related]
90. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
[TBL] [Abstract][Full Text] [Related]
91. An evaluation of the diagnostic equivalence of
Poirier SE; Kwan BYM; Jurkiewicz MT; Samargandy L; Iacobelli M; Steven DA; Lam Shin Cheung V; Moran G; Prato FS; Thompson RT; Burneo JG; Anazodo UC; Thiessen JD
Epilepsy Res; 2021 May; 172():106583. PubMed ID: 33636504
[TBL] [Abstract][Full Text] [Related]
92. 18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC).
Bernstine H; Domachevsky L; Nidam M; Goldberg N; Abadi-Korek I; Shpilberg O; Groshar D
Medicine (Baltimore); 2018 Apr; 97(16):e0490. PubMed ID: 29668631
[TBL] [Abstract][Full Text] [Related]
93. Combined average standard uptake value and rate constant can predict expression of EGFR in hypopharyngeal squamous cell carcinoma: A pilot study with integrated PET/MRI.
Zhang L; Meng Z; Huang C; Xian J
Eur J Radiol; 2024 Mar; 172():111326. PubMed ID: 38280301
[TBL] [Abstract][Full Text] [Related]
94. Detection of early amnestic mild cognitive impairment without significantly objective memory impairment: a case-controlled study.
Murayama N; Iseki E; Fujishiro H; Yamamoto R; Ota K; Suzuki M; Nagashima K; Arai H; Sato K
Psychogeriatrics; 2010 Jun; 10(2):62-8. PubMed ID: 20738809
[TBL] [Abstract][Full Text] [Related]
95.
Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL
Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339
[TBL] [Abstract][Full Text] [Related]
96. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.
Gardener SL; Sohrabi HR; Shen KK; Rainey-Smith SR; Weinborn M; Bates KA; Shah T; Foster JK; Lenzo N; Salvado O; Laske C; Laws SM; Taddei K; Verdile G; Martins RN
J Alzheimers Dis; 2016 Mar; 52(2):661-72. PubMed ID: 27031482
[TBL] [Abstract][Full Text] [Related]
97. Brain imaging of sequential acquisition using a flexible PET scanner and 3-T MRI: quantitative and qualitative assessment.
Nakajima S; Fushimi Y; Hinoda T; Sakata A; Okuchi S; Arakawa Y; Ishimori T; Nakamoto Y
Ann Nucl Med; 2023 Apr; 37(4):209-218. PubMed ID: 36585566
[TBL] [Abstract][Full Text] [Related]
98. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
Tripathi M; Sharma R; Varshney R; Jaimini A; Jain J; Souza MM; Bal J; Pandey S; Kumar N; Mishra AK; Mondal A
Clin Nucl Med; 2012 Feb; 37(2):158-63. PubMed ID: 22228339
[TBL] [Abstract][Full Text] [Related]
99. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
100. Diagnostic Value of
Solnes LB; Jones KM; Rowe SP; Pattanayak P; Nalluri A; Venkatesan A; Probasco JC; Javadi MS
J Nucl Med; 2017 Aug; 58(8):1307-1313. PubMed ID: 28209905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
